JPS5282716A - Antihemophilia factor containing composition and its solubilization - Google Patents

Antihemophilia factor containing composition and its solubilization

Info

Publication number
JPS5282716A
JPS5282716A JP15299476A JP15299476A JPS5282716A JP S5282716 A JPS5282716 A JP S5282716A JP 15299476 A JP15299476 A JP 15299476A JP 15299476 A JP15299476 A JP 15299476A JP S5282716 A JPS5282716 A JP S5282716A
Authority
JP
Japan
Prior art keywords
solubilization
containing composition
factor containing
antihemophilia factor
antihemophilia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15299476A
Other languages
Japanese (ja)
Inventor
Reimondo Tomasu Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/729,758 external-priority patent/US4089944A/en
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of JPS5282716A publication Critical patent/JPS5282716A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP15299476A 1975-12-22 1976-12-21 Antihemophilia factor containing composition and its solubilization Pending JPS5282716A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64317875A 1975-12-22 1975-12-22
US05/729,758 US4089944A (en) 1975-12-22 1976-10-05 Rapidly solubilized AHF composition and process for preparing same

Publications (1)

Publication Number Publication Date
JPS5282716A true JPS5282716A (en) 1977-07-11

Family

ID=27094202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15299476A Pending JPS5282716A (en) 1975-12-22 1976-12-21 Antihemophilia factor containing composition and its solubilization

Country Status (7)

Country Link
JP (1) JPS5282716A (en)
AT (1) AT351158B (en)
CA (1) CA1066189A (en)
DE (1) DE2653534C2 (en)
ES (1) ES454453A1 (en)
GB (1) GB1540610A (en)
MX (1) MX4730E (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001508806A (en) * 1997-09-18 2001-07-03 フマン・エル・テー Pharmaceutical composition containing plasma protein

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
DE2916711A1 (en) * 1979-04-25 1980-11-06 Behringwerke Ag Blood coagulation factors and process for their manufacture
DE3432083A1 (en) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg PASTEURIZED, ISOAGGLUTININ-FREE FACTOR VIII PREPARATION AND METHOD FOR THE PRODUCTION THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826533A (en) * 1954-03-15 1958-03-11 Cutter Lab Stable fibrinogen solutions and method for producing same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001508806A (en) * 1997-09-18 2001-07-03 フマン・エル・テー Pharmaceutical composition containing plasma protein

Also Published As

Publication number Publication date
CA1066189A (en) 1979-11-13
DE2653534C2 (en) 1986-08-28
ES454453A1 (en) 1978-04-01
GB1540610A (en) 1979-02-14
MX4730E (en) 1982-08-24
ATA956676A (en) 1978-12-15
AT351158B (en) 1979-07-10
DE2653534A1 (en) 1977-06-30

Similar Documents

Publication Publication Date Title
JPS5237989A (en) Photopolimerization and composition thereof
ZA764348B (en) Composition for topical application and use thereof
JPS51118844A (en) Nonngreasy composition
JPS51143667A (en) 11substituted aralkylimidazoles and substituted arylcyanoalkylimidazoles and substituted diarylcyanoalkylimidazoles
JPS521035A (en) Vihicle composition containing 11substituted azacycloalkanee22 one
JPS5274657A (en) Silicone composition and its use
GB1550882A (en) Photosensitive composition and its use
EG12289A (en) Microbicial composition
JPS5218809A (en) Phalmacological composition
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
JPS5262263A (en) Esteranic steroid and pharmaceutical composition thereof
JPS5236632A (en) Composition containing impurityydecreasing bissbiguanide
ZA761508B (en) Insecticidal and acaridical composition
JPS51112508A (en) Composition
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
AU1437876A (en) Cosmetic composition
JPS5320433A (en) Pharmaceutical composition and application
JPS5282716A (en) Antihemophilia factor containing composition and its solubilization
JPS527419A (en) Heterocolloidal deblicin containing medical composition and its preparation
PH14015A (en) Naphthyridinylisoindolinones and pharmaceucal compositions containing them
AU1100676A (en) Anti-histomonal composition
JPS55149273A (en) Novel 33furyllbetaachalcogennalkylsulfide* its manufacture and composition using same